A phase II dose-ranging study of mirabegron in patients with overactive bladder

被引：0
|
作者：
Christopher R. Chapple
Vladimir Dvorak
Pjotr Radziszewski
Philip Van Kerrebroeck
Jean Jacques Wyndaele
Brigitte Bosman
Peter Boerrigter
Ted Drogendijk
Arwin Ridder
Ingrid Van Der Putten-Slob
Osamu Yamaguchi
机构：
[1] Sheffield Teaching Hospitals,Department of Urology, Royal Hallamshire Hospital
[2] Centrum ambulantní gynekologie a primární péce,Department of Urology
[3] Medical University Warsaw,Department Urology
[4] Maastricht University Medical Center,Department of Urology
[5] Antwerp University and Antwerp University Hospital,Division of Bioengineering and LUTD Research, School of Engineering
[6] Astellas Pharma Europe BV,undefined
[7] Nihon University,undefined
来源：
International Urogynecology Journal | 2013年 / 24卷
关键词：
β; -adrenoceptor agonist; Mirabegron; Overactive; Urinary bladder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1447 / 1458
页数：11
相关论文
共 50 条
  • [1] A phase II dose-ranging study of mirabegron in patients with overactive bladder
    Chapple, Christopher R.
    Dvorak, Vladimir
    Radziszewski, Pjotr
    Van Kerrebroeck, Philip
    Wyndaele, Jean Jacques
    Bosman, Brigitte
    Boerrigter, Peter
    Drogendijk, Ted
    Ridder, Arwin
    Van der Putten-Slob, Ingrid
    Yamaguchi, Osamu
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 (09) : 1447 - 1458
  • [2] Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)
    Abrams, Paul
    Kelleher, Con
    Staskin, David
    Rechberger, Tomasz
    Kay, Richard
    Martina, Reynaldo
    Newgreen, Donald
    Paireddy, Asha
    van Maanen, Rob
    Ridder, Arwin
    EUROPEAN UROLOGY, 2015, 67 (03) : 577 - 588
  • [3] Re: Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-Blind, Dose-Ranging, Phase 2 Study (Symphony)
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2015, 193 (01): : 218 - 219
  • [4] Re: Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)
    Cruz, Francisco
    EUROPEAN UROLOGY, 2015, 67 (06) : 1189 - 1190
  • [5] DOSE-RANGING STUDY OF ONCE-DAILY MIRABEGRON (YM178), A NOVEL SELECTIVE β3-ADRENOCEPTOR AGONIST, IN PATIENTS WITH OVERACTIVE BLADDER (OAB)
    Chapple, C.
    Wyndaele, J. J.
    Van Kerrebroeck, P.
    Radziszewski, P.
    Dvorak, V.
    Boerrigter, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 249 - 249
  • [6] Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)
    Abrams, P.
    Kelleher, C.
    Staskin, D.
    Kay, R.
    Martan, A.
    Mincik, I.
    Newgreen, D.
    Ridder, A.
    Paireddy, A.
    van Maanen, R.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (05) : 827 - 838
  • [7] Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)
    P. Abrams
    C. Kelleher
    D. Staskin
    R. Kay
    A. Martan
    I. Mincik
    D. Newgreen
    A. Ridder
    A. Paireddy
    R. van Maanen
    World Journal of Urology, 2017, 35 : 827 - 838
  • [8] Dose effect of ipilimumab in patients with advanced melanoma: Results from a phase II, randomized, dose-ranging study
    Hamid, O.
    Chin, K.
    Li, J.
    Neyns, B.
    Linette, G.
    Negrier, S.
    Lutzky, J.
    Hoos, A.
    Wolchock, J.
    Lebbe, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India
    Jha, Tara K.
    Sundar, Shyam
    Thakur, Chandreshwar P.
    Sabin, Antony J.
    Horton, John
    Felton, J. Mark
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 78 - 78
  • [10] A phase II dose-ranging study of topical resiquimod to treat actinic keratosis
    Szeimies, R. -M.
    Bichel, J.
    Ortonne, J. -P.
    Stockfleth, E.
    Lee, J.
    Meng, T-C.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (01) : 205 - 210
12345